Top Stories
-
A combination of genetic and lab testing could identify 1 million Americans who are at risk of early death from heart disease because they carry a gene that causes high cholesterol.
Topic
-
The Columbia Hypertension Center has been certified by the American Heart Association, recognition that Columbia is a leader in the care of patients with high blood pressure.
-
Internationally renowned “surgeon’s surgeon” is known for his skill in highly complex cases.
Topic
-
Heart disease is the No. 1 one cause of death in American women, yet most are unaware of the risks and most cardiovascular studies are about men.
Topic
Latest News
- August 1, 2017
Aspirin does not increase the risk of hospitalization or death in patients taking ACE inhibitors or ARBs for heart failure, Columbia researchers have found.
- August 1, 2017
Using a noninvasive test developed at Columbia, older TAVR patients with an unusual heart failure pattern were found to have cardiac amyloidosis.
Topic
- May 1, 2017
Smoking counteracts the effect of a gene that normally protects against heart disease, according to a new study.
Topic
- March 6, 2017
Columbia University names cardiology researchers Muredach P. Reilly and Marwah Abdalla 2017 Marjorie and Lewis Katz Scholars.
Topic
- March 1, 2017
Researchers have found that only 16 percent of heart attack survivors get the recommended amount of physical activity in the weeks after hospitalization.
Topic
- January 20, 2017
A new study from Columbia University researchers estimates that 17 million Americans who have normal blood pressure in the doctor's office may have undiagnosed hypertension.
Topic
- December 20, 2016
Children who had heart surgery at NYP/CUMC had a significantly lower risk-adjusted mortality rate compared with all other New York state programs.
Topic
- December 9, 2016
Heart failure is no more common in individuals with sickle cell trait than in the general population, a new study has found.
Topic
- November 1, 2016
An international trial shows that TCEP, a procedure meant to reduce neurological complications, is safe for TAVR patients, though more research is needed on efficacy.
- October 31, 2016
A major international study has found that drug-eluting stents are as effective as surgery for many patients with a blockage in the left main coronary artery.
Topic
